Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study

Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is offered to select patients with peritoneal metastases. In instances of recurrence/progression, a repeat CRS/HIPEC may be considered. The perioperative morbidity and the potential oncologic benefits are not...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2020-12, Vol.27 (13), p.4883-4891
Hauptverfasser:	Powers, Benjamin D., Felder, Seth, Veerapong, Jula, Baumgartner, Joel M., Clarke, Callisia, Mogal, Harveshp, Staley, Charles A., Maithel, Shishir K., Patel, Sameer, Dhar, Vikrom, Lambert, Laura, Hendrix, Ryan J., Abbott, Daniel E., Pokrzywa, Courtney, Raoof, Mustafa, Lee, Byrne, Johnston, Fabian M., Greer, Jonathan, Cloyd, Jordan M., Kimbrough, Charles, Grotz, Travis, Leiting, Jennifer, Fournier, Keith, Lee, Andrew J., Imanirad, Iman, Dessureault, Sophie, Dineen, Sean P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Appendiceal Neoplasms - therapy Appendix Chemotherapy Chemotherapy, Cancer, Regional Perfusion Combined Modality Therapy Cytoreduction Surgical Procedures Gastrointestinal cancer Humans Hyperthermic Intraperitoneal Chemotherapy Medicine Medicine & Public Health Metastases Morbidity Neoplasm Recurrence, Local - therapy Oncology Peritoneal Neoplasms - therapy Peritoneal Surface Malignancy Peritoneum Retrospective Studies Surgery Surgical Oncology Survival Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!